SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-016577
Filing Date
2024-03-29
Accepted
2024-03-29 15:28:18
Documents
5
Effectiveness Date
2024-03-29

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ny20025434x2_s8.htm S-8 92172
2 EXHIBIT 5.1 ny20025434x2_ex5-1.htm EX-5.1 9910
3 EXHIBIT 23.1 ny20025434x2_ex23-1.htm EX-23.1 1735
4 EXHIBIT 107 ny20025434x2_ex107.htm EX-FILING FEES 19555
5 ny20025434x2_ex5-1img01.jpg GRAPHIC 2596
  Complete submission text file 0001140361-24-016577.txt   128215
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278374 | Film No.: 24803928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)